2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.

ABSTRACT:

Background

Data on patients with inflammatory bowel diseases (IBD) who have had 2019 novel coronavirus (SARS-CoV-2) disease (COVID-19) are needed.

Aims

To report the clinical characteristics, including gastrointestinal symptoms, of COVID-19 in IBD patients, and to assess the risk of COVID-19 in IBD.

Methods

This case series included consecutive IBD patients with laboratory-confirmed COVID-19. Age-adjusted cumulative incidences were compared with the general population in the Madrid region.

Results

Through April 8, 12 of 1918 IBD patients were diagnosed with COVID-19. The average age was 52 years, 75% of the patients were female and 58.3% had Crohn's disease. Seven patients (58%) were on maintenance treatment with immunomodulators/biologics, of these four with c

SUBMITTER: Taxonera C 

PROVIDER: S-EPMC7267496 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature